Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record, with a small difference in title or year; 209 of the 209 references it cites were found in a registry or an index.

Value of Primordial and Primary Prevention for Cardiovascular Disease: A Policy Statement From the American Heart Association

Abstract

The process of atherosclerosis may begin in youth and continue for decades, leading to both nonfatal and fatal cardiovascular events, including myocardial infarction, stroke, and sudden death. With primordial and primary prevention, cardiovascular disease is largely preventable. Clinical trial evidence has shown convincingly that pharmacological treatment of risk factors can prevent events. The data are less definitive but also highly suggestive that appropriate public policy and lifestyle interventions aimed at eliminating tobacco use, limiting salt consumption, encouraging physical exercise, and improving diet can prevent events. There has been concern about whether efforts aimed at primordial and primary prevention provide value (ie, whether such interventions are worth what we pay for them). Although questions about the value of therapeutics for acute disease may be addressed by cost-effectiveness analysis, the long time frames involved in evaluating preventive interventions make cost-effectiveness analysis difficult and necessarily flawed. Nonetheless, cost-effectiveness analyses reviewed in this policy statement largely suggest that public policy, community efforts, and pharmacological intervention are all likely to be cost-effective and often cost saving compared with common benchmarks. The high direct medical care and indirect costs of cardiovascular disease—approaching $450 billion a year in 2010 and projected to rise to over $1 trillion a year by 2030—make this a critical medical and societal issue. Prevention of cardiovascular disease will also provide great value in developing a healthier, more productive society.

Overview

Integrity signals

Registry

Crossref · 10.1161/cir.0b013e3182285a81

Cites

209 of 209 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

15 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 209 references

Research works printed but not linked: 14

  1. Prevention for a Healthier America: Investments in Disease Prevention Yield Significant Savings, Stronger Communities. Washington, DC: Trust for America's Health; 2008.
  2. Treating Tobacco Use and Dependence: 2008 Update. Rockville, MD: US Department of Health and Human Services Public Health Service; May 2008.
  3. Secondhand Smoke Exposure and Cardiovascular Effects: Making Sense of the Evidence. Washington, DC: Institute of Medicine; 2009.
  4. Recommended Community Strategies and Measurements to Prevent Obesity. Atlanta, GA: Centers for Disease Control and Prevention; 2009.
  5. Commission on Social Determinants of Health: Final Report. Geneva, Switzerland: World Health Organization; September 2, 2009.
  6. Committee on Secondhand Smoke Exposure and Acute Coronary Events, Institute of Medicine. Secondhand Smoke Exposure and Cardiovascular Effects: Making Sense of the Evidence. Washington, DC: Institute of Medicine; 2009.
  7. Behavioral Risk Surveillance System. Atlanta, GA: Centers for Disease Control and Prevention; 2009.
  8. 10.1093/ajcn/82.1.174 · doi:10.1093/ajcn/82.1.174
  9. Proceedings of the Task Force Meeting: Worksite Reviews. Atlanta, GA: Centers for Disease Control and Prevention; 2007.
  10. Lambrew JM, Podesta JD. Promoting Prevention and Preempting Costs: A New Wellness Trust for the United States. Washington, DC: Center for American Progress; 2006.
  11. Fruit and Vegetable Consumption Among Adults: United States, 2005. Atlanta, GA: Centers for Disease Control and Prevention; 2007;56:213–217.
  12. Smoking Cessation Policy: The Economic Benefit. Washington, DC: American Lung Association; September 14, 2010.
  13. National Center for Health Statistics: National Health Interview Survey. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Health Statistics; 2006.
  14. Alchian A. The meaning of utility measurement. Am Econ Rev. 1953;43:26–50.

Cited by

See all 541

Metadata

Authors
Weintraub, W. S., Daniels, S. R., Burke, L. E., Franklin, B. A., Goff, D. C., Hayman, L. L., Lloyd-Jones, D., Pandey, D. K., Sanchez, E. J., Schram, A. P., & Whitsel, L. P.
Venue
Circulation
Published
2011-08-23
Volume
124
Issue
8
Pages
967-990
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2009642737
Cited by
541
References
209
Citations by year
2026: 23 · 2025: 21 · 2024: 38 · 2023: 34 · 2022: 40 · 2021: 36 · 2020: 29 · 2019: 29 · 2018: 41 · 2017: 27 · 2016: 33 · 2015: 54 · 2014: 41 · 2013: 45 · 2012: 46
FWCI
42.40
Type
journal article
Language
en
Open access
closed
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
  • D-Scholarship@Pitt (University of Pittsburgh) (acceptedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Keywords
cardiovascular disease prevention, primordial prevention, primary prevention, cost-effectiveness, atherosclerosis, public health policy, lifestyle intervention, tobacco use, salt intake, physical activity, cardiovascular disease costs
MeSH terms
American Heart Association, Cardiovascular Diseases, Humans, Risk Factors, United States, Evidence-Based Medicine, Risk Reduction Behavior

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Value of Primordial and Primary Prevention for Cardiovascular Disease: A Policy Statement From the American Heart Association. https://app.cochat.ai/papers/10.1161/cir.0b013e3182285a81
The paper
Weintraub, W. S., Daniels, S. R., Burke, L. E., Franklin, B. A., Goff, D. C., Hayman, L. L., Lloyd-Jones, D., Pandey, D. K., Sanchez, E. J., Schram, A. P., & Whitsel, L. P. (2011). Value of Primordial and Primary Prevention for Cardiovascular Disease: A Policy Statement From the American Heart Association. Circulation. https://doi.org/10.1161/cir.0b013e3182285a81

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.